Already at best price
Normocare-M Tablet SR
Metformin (500mg) + Myo-Inositol (600mg)
Bestel Laboratories Pvt Ltd
Anti-Diabetic
₹249.00
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
₹249.00
Active composition
Metformin 500 mg
+1 more active ingredient
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medicine Strength
500 mg
All Active Ingredients
Metformin500 mg
Myo-Inositol600 mg
Uses & Benefits
Medical applications
Diabetes
Normocare-M Tablet SR is a pharmaceutical formulation designed for the management of type 2 diabetes mellitus. Each extended-release tablet contains 500mg Metformin hydrochloride and 600mg Myo-Inositol, a dietary supplement believed to augment the benefits of Metformin. Metformin, a biguanide, works by decreasing the production of glucose in the liver and improving the body's response to insulin. Myo-Inositol is believed to enhance insulin sensitivity and improve lipid metabolism. This combined therapy aims to maintain blood glucose levels within the normal range, thereby reducing the risk of long-term diabetes complications. It is essential to follow the prescribed dosage and regular monitoring of blood glucose levels by a healthcare professional to ensure safe and effective treatment.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
Information regarding the use of Normocare-M Tablet SR during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Normocare-M Tablet SR during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
Normocare-M Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Normocare-M Tablet SR may be needed. Please consult your doctor. Use of Normocare-M Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Normocare-M Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Normocare-M Tablet SR may be needed. Please consult your doctor. Normocare-M Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Customer Reviews
0 reviews for Normocare-M Tablet SR
Normocare-M Tablet SR
1 / 3
Rx RequiredSchedule H
Normocare-M Tablet SR
Metformin (500mg) + Myo-Inositol (600mg)
₹249.00
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
Cheaper alternative availability
Not Foundfor this medicine
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Metformin 500 mg
+1 more active ingredient
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medicine Strength
500 mg
All Active Ingredients
Metformin500 mg
Myo-Inositol600 mg
Uses & Benefits
Medical applications
Diabetes
Normocare-M Tablet SR is a pharmaceutical formulation designed for the management of type 2 diabetes mellitus. Each extended-release tablet contains 500mg Metformin hydrochloride and 600mg Myo-Inositol, a dietary supplement believed to augment the benefits of Metformin. Metformin, a biguanide, works by decreasing the production of glucose in the liver and improving the body's response to insulin. Myo-Inositol is believed to enhance insulin sensitivity and improve lipid metabolism. This combined therapy aims to maintain blood glucose levels within the normal range, thereby reducing the risk of long-term diabetes complications. It is essential to follow the prescribed dosage and regular monitoring of blood glucose levels by a healthcare professional to ensure safe and effective treatment.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
Information regarding the use of Normocare-M Tablet SR during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Normocare-M Tablet SR during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
Normocare-M Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Normocare-M Tablet SR may be needed. Please consult your doctor. Use of Normocare-M Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Normocare-M Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Normocare-M Tablet SR may be needed. Please consult your doctor. Normocare-M Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Customer Reviews
0 reviews for Normocare-M Tablet SR
%22%2F%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22158%22%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%20font-size%3D%2244%22%20font-weight%3D%22800%22%20text-anchor%3D%22middle%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.45%22%20transform%3D%22rotate(-16%20150%20158)%22%3EDrugIndia%3C%2Ftext%3E%0A%3Cg%20fill%3D%22%23fb7185%22%20opacity%3D%220.5%22%3E%3Cpath%20d%3D%22M44%2048h6v6h6v6h-6v6h-6v-6h-6v-6h6z%22%2F%3E%3Cpath%20d%3D%22M250%20214h5v5h5v5h-5v5h-5v-5h-5v-5h5z%22%2F%3E%3C%2Fg%3E%0A%3Cellipse%20cx%3D%22150%22%20cy%3D%22120%22%20rx%3D%22118%22%20ry%3D%2286%22%20fill%3D%22url(%23glow)%22%2F%3E%0A%3Cg%20transform%3D%22rotate(-28%20150%20120)%22%20filter%3D%22url(%23soft)%22%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%3E%0A%3Crect%20x%3D%2289%22%20y%3D%2297%22%20width%3D%22122%22%20height%3D%2246%22%20rx%3D%2223%22%20fill%3D%22url(%23cap)%22%2F%3E%0A%3Cpath%20d%3D%22M89%20120a23%2023%200%200%201%2023-23h38v46h-38a23%2023%200%200%201-23-23z%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.16%22%2F%3E%0A%3Cline%20x1%3D%22150%22%20y1%3D%2298%22%20x2%3D%22150%22%20y2%3D%22142%22%20stroke%3D%22%23ffffff%22%20stroke-width%3D%222%22%20opacity%3D%220.55%22%2F%3E%0A%3Cellipse%20cx%3D%22118%22%20cy%3D%22110%22%20rx%3D%2215%22%20ry%3D%225%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.4%22%2F%3E%0A%3C%2Fg%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22206%22%20font-size%3D%2222%22%20font-weight%3D%22700%22%20letter-spacing%3D%220.2%22%20text-anchor%3D%22middle%22%20fill%3D%22%237c2d12%22%3ESITARAY%20M%3C%2Ftext%3E%3Ctext%20x%3D%22150%22%20y%3D%22232%22%20font-size%3D%2222%22%20font-weight%3D%22700%22%20letter-spacing%3D%220.2%22%20text-anchor%3D%22middle%22%20fill%3D%22%237c2d12%22%3E50%2F500MG%20TAB%3C%2Ftext%3E%0A%3Cg%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22271%22%20font-size%3D%2215%22%20font-weight%3D%22800%22%20letter-spacing%3D%221.5%22%20text-anchor%3D%22middle%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.85%22%3EDRUGINDIA%3C%2Ftext%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22270%22%20font-size%3D%2215%22%20font-weight%3D%22800%22%20letter-spacing%3D%221.5%22%20text-anchor%3D%22middle%22%20fill%3D%22%23c2410c%22%3EDRUGINDIA%3C%2Ftext%3E%0A%3C%2Fg%3E%0A%3C%2Fsvg%3E)